Memantine
(Redirected from Marixino)
Medication used to treat Alzheimer's disease
| Drug Information | |||
|---|---|---|---|
| Image | 200 | ||
| Identifiers
|
Chemical Data
O Molecular Weight | ||
Memantine is a medication used to treat moderate-to-severe Alzheimer's disease. It is less preferred than acetylcholinesterase inhibitors such as donepezil and rivastigmine. Memantine is taken by mouth.
Medical uses[edit | edit source]
Memantine is primarily used for the treatment of Alzheimer's disease. It is believed to work by blocking NMDA receptors, which are involved in synaptic plasticity and memory. This action helps to reduce the symptoms of Alzheimer's disease, such as cognitive decline and memory loss.
Side effects[edit | edit source]
Common side effects of memantine include dizziness, headache, confusion, and constipation. Serious side effects are rare but can include hallucinations, hypertension, and seizures.
Pharmacology[edit | edit source]
Memantine is an NMDA receptor antagonist. It binds to the NMDA receptor with a higher affinity than magnesium ions, which are naturally present in the synapse. This binding prevents excessive calcium influx into the neuron, which can lead to neuronal damage and cell death.
Pharmacokinetics[edit | edit source]
Memantine is well absorbed after oral administration, with a bioavailability of nearly 100%. It is minimally metabolized in the liver and is primarily excreted unchanged in the urine. The elimination half-life of memantine is between 60 and 100 hours.
History[edit | edit source]
Memantine was first synthesized and developed by Eli Lilly and Company in the 1960s. It was later marketed by Merz Pharmaceuticals under the brand name Namenda. It was approved for the treatment of Alzheimer's disease in the United States by the Food and Drug Administration (FDA) in 2003.
Research[edit | edit source]
Research is ongoing to explore the potential use of memantine in other neurological disorders, such as Parkinson's disease, Huntington's disease, and multiple sclerosis. Studies are also being conducted to investigate its effects on depression and anxiety.
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
